pharmaceuticals Article New Sulfanilamide Derivatives Incorporating Heterocyclic Carboxamide Moieties as Carbonic Anhydrase Inhibitors Andrea Angeli 1,2,* , Victor Kartsev 3, Anthi Petrou 4 , Mariana Pinteala 2 , Roman M. Vydzhak 5, Svitlana Y. Panchishin 5 , Volodymyr Brovarets 5, Viviana De Luca 6, Clemente Capasso 6 , Athina Geronikaki 4,* and Claudiu T. Supuran 1 1 Department of Chemistry “Ugo Schiff”, University of Florence, Via della Lastruccia 3-13, 50019 Sesto Fiorentino, Italy; claudiu.supuran@unifi.it 2 Centre of Advanced Research in Bionanoconjugates and Biopolymers Department, “Petru Poni” Institute of Macromolecular Chemistry, 707410 Iasi, Romania;
[email protected] 3 InterBioScreen, Chernogolovka, 142432 Chernogolovka, Moscow Region, Russia;
[email protected] 4 Department of Pharmacy, School of Health, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece;
[email protected] 5 Department of Chemistry of Bioactive Nitrogen-Containing Heterocyclic Bases, V.P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry, NAS of Ukraine 1, Murmanska St, 02094 Kyiv, Ukraine;
[email protected] (R.M.V.);
[email protected] (S.Y.P.);
[email protected] (V.B.) 6 Institute of Biosciences and Bioresources, CNR, Via Pietro Castellino 111, 80131 Napoli, Italy;
[email protected] (V.D.L.);
[email protected] (C.C.) * Correspondence: andrea.angeli@unifi.it (A.A.);
[email protected] (A.G.); Tel.: +30-230-199-7616 (A.G.) Citation: Angeli, A.; Kartsev, V.; Abstract: Carbonic Anhydrases (CAs) are ubiquitous metalloenzymes involved in several disease Petrou, A.; Pinteala, M.; Vydzhak, conditions. There are 15 human CA (hCA) isoforms and their high homology represents a challenge R.M.; Panchishin, S.Y.; Brovarets, V.; for the discovery of potential drugs devoid of off-target side effects.